S.BIOMEDICS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30,850 KRW | -9.26% |
|
-22.19% | +168.26% |
| 2023 | S.Biomedics CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2023 | S.Biomedics CO., LTD. has completed an IPO in the amount of KRW 13.5 billion. | CI |
Valuation
| Fiscal Period: December | 2023 |
|---|---|
| Capitalization 1 | 130,376 |
| Enterprise Value (EV) 1 | 131,714 |
| P/E ratio | -16.7 x |
| Yield | - |
| Capitalization / Revenue | 9.95 x |
| EV / Revenue | 10 x |
| EV / EBITDA | -29.7 x |
| EV / FCF | -16.5 x |
| FCF Yield | -6.05% |
| Price to Book | 18.8 x |
| Nbr of stocks (in thousands) | 11,337 |
| Reference price 2 | 11,500 |
| Announcement Date | 3/21/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 |
|---|---|
| Net sales 1 | 13,108 |
| EBITDA 1 | -4,436 |
| EBIT 1 | -5,989 |
| Operating Margin | -45.69% |
| Earnings before Tax (EBT) 1 | -6,337 |
| Net income 1 | -7,524 |
| Net margin | -57.39% |
| EPS 2 | -688.2 |
| Free Cash Flow 1 | -7,972 |
| FCF margin | -60.82% |
| FCF Conversion (EBITDA) | - |
| FCF Conversion (Net income) | - |
| Dividend per Share | - |
| Announcement Date | 3/21/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 |
|---|---|
| Net Debt 1 | 1,337 |
| Net Cash position 1 | - |
| Leverage (Debt/EBITDA) | -0.3015 x |
| Free Cash Flow 1 | -7,972 |
| ROE (net income / shareholders' equity) | -97.1% |
| ROA (Net income/ Total Assets) | -13.3% |
| Assets 1 | 56,585 |
| Book Value Per Share 2 | 611.0 |
| Cash Flow per Share 2 | 124.0 |
| Capex 1 | 1,847 |
| Capex / Sales | 14.09% |
| Announcement Date | 3/21/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +168.26% | 259M | |
| -3.15% | 89.69B | |
| +3.95% | 41.34B | |
| -10.51% | 33.72B | |
| +59.25% | 26.11B | |
| -20.09% | 14.63B | |
| -8.92% | 12.84B | |
| -11.46% | 11.66B | |
| -43.05% | 11.52B | |
| +4.34% | 8.92B |
- Stock Market
- Equities
- A304360 Stock
- Financials S.Biomedics CO., LTD.